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Abstract
 
DM facilitates formation of high affinity complexes of peptide–major histocompatibility com-
plex (MHC) by release of class II MHC–associated invariant chain peptide (CLIP). This has
been proposed to occur through discrimination of complex stability. By probing kinetic and
conformational intermediates of the wild-type and mutant human histocompatibility leukocyte
antigen (HLA)-DR1–peptide complexes, and examining their reactivities with DM, we pro-
pose that DM interacts with the flexible hydrophobic pocket 1 of DR1 and converts the mol-
ecule into a conformation that is highly peptide receptive. A more rigid conformation, gener-
ated upon filling of pocket 1, is less susceptible to DM effects. Thus, DM edits peptide–MHC
by recognition of the flexibility rather than stability of the complex.
Key words: antigen processing • molecular conformation • HLA-DR antigens • surface 
plasmon resonance • ﬂuorometry
 
Introduction
 
HLA-DM or H2-M in mice, a nonclassical HLA molecule,
has been shown to play a critical role in loading antigenic
peptides to newly synthesized MHC class II molecules.
The significance of DM function is exemplified by the
finding that MHC class II molecules isolated from DM-
negative cells were largely occupied with class II MHC–
 
associated invariant chain peptide (CLIP)
 
1
 
 (1). Consequently,
DR molecules isolated from these mutant cells were prone
to SDS denaturation at room temperature (2). Since its dis-
covery, several other functions have been attributed to
DM, including stabilization of empty class II molecules (3,
4) and peptide editing for selection of peptides that form
stable complexes with MHC class II (5) by an enzyme-like
mechanism (6, 7). Nevertheless, although DM accelerates
dissociation of some peptide–MHC complexes, other com-
plexes remain resistant to DM-induced dissociation (5,
7–11). Furthermore, a chaperone-like function for DM has
also been proposed (5). The crystal structures of HLA-DM
(12) and H2-M (13) have been resolved and they do not
exhibit a groove to accommodate a peptide. Thus, the
mechanism of DM reactivity remains unsolved.
It is now established that conformational changes in the
structure of MHC molecules are associated with peptide
binding (14–21). Class II molecules that are empty or have
 
lost their peptide are less rigid (floppy conformation)
 
 
 
and
migrate with a larger apparent molecular mass or fall apart
on SDS-PAGE. Stable peptide–class II complexes migrate
faster than the floppy conformation, indicating their more
compact and rigid conformation (compact dimer [14–17,
22]). Recently, we demonstrated that the SDS stability of
DR1 complexes correlates with the burial of hydrophobic
residues in pocket 1. DR1 molecules in complex with
peptides that lack anchor residue in corresponding
pocket 1 form floppy conformations and fall apart in SDS
gels (23). When a peptide like influenza virus hemaggluti-
nin (HA)
 
306–318
 
, which has a tyrosine anchor fitting in
pocket 1, binds DR1, the complex becomes compact and
resists SDS-induced denaturation (17, 24).
The rate-limiting step in formation of stable peptide–
MHC complexes occurs in generation of a receptive class II
conformation (19, 20). A receptive conformation is created
when a resident peptide dissociates. At this time, a second
peptide can bind class II almost spontaneously and stochio-
metrically (19, 20). This receptive molecule has a flexible
conformation with a very short half-life. In the absence of
any free peptide, this flexible molecule rapidly reverts to a
“closed” conformation that binds slowly to the subse-
 
quently offered peptide (20). A mutant DR1, DR1
 
b
 
G86Y
 
,
that remains permanently in receptive or “open” form was
designed by introducing a single site-specific mutation.
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Abbreviations used in this paper: 
 
AMCA, 7-amino-4-methyl-coumarin-
3-acetic acid; CLIP, class II MHC–associated invariant chain peptide;
HA,
 
 
 
hemagglutinin; RU, resonance unit; SPR, surface plasmon reso-
nance; wt, wild-type. 
1698
 
DM Interacts with Floppy DR1
 
b
 
86G was changed to tyrosine presumably to fill pocket 1
and rescue the flexible pocket from collapsing (23, 24).
Thus, the conformation of mutant DR1 partially resembles
wild-type (wt)DR1 in complex with a peptide that has ty-
rosine as the main anchor. The molecule is rigid and open,
and thus can bind and dissociate peptides efficiently.
In accord with these in vitro findings, the process of syn-
thesis, maturation, and export of class II molecules through
the endocytic pathway involves conformational changes in
the structure of MHC (25, 26). A class II invariant chain
peptide, CLIP, acts as a surrogate short-lived peptide for
shaping of MHC class II (27). In peptide-loading compart-
ments, CLIP dissociates, leaving a receptive groove “open”
for efficient peptide binding. Similar to empty soluble DR1
molecules that aggregate in the absence of peptides (22),
class II molecules tend to aggregate in the absence of in-
variant chains (28).
As DM seems to be involved in class II peptide–loading
processes, we considered different conformations of MHC
as potential ligands for DM. By probing conformational
changes that exist between wt and DR1
 
b
 
G86Y 
 
and their
reactivities with DM, we propose the following mecha-
nism for DM function: through hydrophobic interactions
around pocket 1, DM recognizes a flexible conformation of
pocket 1 of DR1 and accelerates dissociation of CLIP or a
peptide that lacks the pocket 1 anchor. This interaction
converts the molecule into a highly receptive conformation
for peptide binding. A compact class II that is generated
upon binding of a peptide with a large hydrophobic side
chain at corresponding pocket 1 yields a rigid conformation
that is less responsive to DM.
 
Materials and Methods
 
Production of Recombinant Soluble DR1 and DM Proteins.
 
Solu-
ble DR1 proteins were expressed and purified as described (23).
DM, expressed and isolated as described previously (8), was fur-
ther purified by gel filtration (Superdex 200; Amersham Pharma-
cia Biotech) and ion-exchange chromatography (Mono-Q
Sepharose; Amersham Pharmacia Biotech [12]).
 
Peptide Synthesis and Labeling.
 
HA peptides, CPKYVK-
QNTLKLAT, HA
 
305–318
 
, and several variants, HA
 
Y308A
 
 (CPK-
AVKQNTLKLAT), and Cys-HA
 
Anchorless
 
 (CPKAVKANGAK-
AAT) were purified to apparent homogeneity of 
 
.
 
95% by
reverse-phase preparative HPLC and their identities were con-
firmed by mass spectrometry. Then, 0.15 mM HA
 
305–318
 
 or
HA
 
Anchorless
 
,
 
 
 
containing a single cysteine in 10 ml PBS, was incu-
bated with 25 
 
m
 
l of 75 mM fluorescein-5-maleimide (Molecular
Probes) in 
 
N
 
,
 
N
 
-dimethylformamide (DMF) for 1 h at room tem-
perature. The samples were concentrated to 1 ml by SpeedVac
(Savant Instruments, Inc.). The excess free fluorescence label was
removed by passing through a Sephadex G-10 column (Amer-
sham Pharmacia Biotech). The concentration was determined
by the extinction coefficient of fluorescein-5-maleimide (83
mM
 
2
 
1
 
cm
 
2
 
1
 
).
 
Peptide Association and Dissociation Assays.
 
Purified wtDR1 or
DR1
 
b
 
G86Y
 
 (2.4 
 
m
 
M) was incubated in the absence or presence of
1 
 
m
 
M DM with 100 
 
m
 
M fluorescence-labeled HA
 
Anchorless
 
 peptide
for various times in 0.15 M citric phosphate buffer, pH 6.0, at
37
 
8
 
C. After removal of free peptides by a Sephadex G-50 spin
 
column equilibrated with PBS, fluorescence emission of the
DR–FITC–HA
 
Anchorless
 
 complex was measured at 514 nm with
an excitation at 490 nm on an LS-50B spectrofluorimeter (Per-
kinElmer) at room temperature. The fluorescence emission
of the DR–7-amino-4-methyl-coumarin-3-acetic acid (AMCA)–
HA
 
Anchorless 
 
complex was measured at 445 nm with excitation at
350 nm. Dissociation experiments with wtDR1 and DR1
 
b
 
G86Y
 
 com-
plexes were performed essentially as described previously (20, 23).
 
Data Analysis.
 
All the raw association data in Fig. 2 were fit-
ted into either single or double exponential association equations
as follows:
 
(1)
(2)
 
All the raw dissociation data were fitted into either single or dou-
ble exponential dissociation equations as follows:
 
(3)
(4)
 
Intrinsic Fluorescence Measurement.
 
Steady-state tryptophan flu-
orescence measurements were done in 0.15 M citric phosphate
buffer, pH 6.0, at 37
 
8
 
C. For this experiment, 1 
 
m
 
M DM and 2
 
m
 
M DR1 were used. An SLM 48000 spectrofluorimeter config-
ured in the T format was used. Emission was monitored from
310 to 500 nm with excitation at 295 nm. The excitation slit
width was 4 nm. The temperature was controlled by a circulating
temperature bath (Neslab), and samples were continuously stirred
by a magnetic stirrer.
 
Real Time Binding Experiments.
 
For peptide immobilization
to the biosensor CM5 chip (BIAcore), the surface was activated
by injecting a mixture containing equal amounts of 0.05 M
 
N
 
-hydroxy-succinimide (NHS) and 0.2 M 
 
N
 
-ethyl-
 
N
 
9
 
 (dimeth-
ylaminopropyl) carbodiimide (EDC) at a low rate of 10 
 
m
 
l/min
for 7 min. Amino groups were generated by injection of ethyl-
enediamine hydrochloride (1 M, pH 6.0) for 8 min at a flow rate
of 10 
 
m
 
l/min. To introduce maleimido groups, a solution of the
heterobifunctional reagent, Sulfo-succinimidyl 4-(
 
p
 
-maleimi-
dophenyl)-butyrate (SMPB; Pierce Chemical Co.), was pumped
over the surface for 10 min. Cysteine peptides (100–200 
 
m
 
M)
were injected to desired levels.
All binding experiments with use of biosensor were performed
in 0.15 M citrate/phosphate buffer at pH 6.0. The pH 6.0 was
chosen because the optimal activity of DM is shown to be at the
pH range of 4.5–6. However, at pH levels 
 
,
 
6.0, the BIAcore
dextran chip undergoes some changes that lead to a false increase
in the resonance unit (RU) levels. Thus, we tested the above pH
range for our BIAcore experiments, and selected pH 6.0 because
the observed bindings were real, and complexes formed dissoci-
ated within the expected dissociation rates for different pairs of
peptide–MHC. On the contrary, at pH 
 
# 
 
5.8 the nonspecific ef-
fects were apparent. Soluble DR1 was incubated with 200 
 
m
 
M
HA
 
Y308A
 
 peptide at 37
 
8
 
C for 36 h. Size-exclusion HPLC (Super-
dex 200 gel filtration column; Amersham Pharmacia Biotech)
was then used to isolate the sDR1–HA
 
Y308A
 
 complexes. The
complexes were further concentrated by centrifugal filter devices
(Millipore). The concentration of the complex was determined
by absorbance at 280 nm with the extinction coefficient of
77,000 M
 
2
 
1
 
cm
 
2
 
1
 
. The complex was incubated at 37
 
8
 
C for 20
min with or without 1 
 
m
 
M DM and injected to the peptide sur-
faces. For dissociation experiments, 9 
 
m
 
M DM in citrate buffer,
pH 6.0, was injected over the preformed complexes, wtDR1–
YY 0 A1 1e
xt ¤ 1 – – () + =
YY 0 A1 1e
xt 1 ¤ – – () A2 1 e
xt 1 ¤ – – () . ++ =
YY 0 A1e
xt 1 ¤ – + =
YY 0 A1e
xt 1 ¤ – A2e
xt 2 ¤ –˙ . ++ = 
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HA
 
306–318
 
, wtDR1–HA
 
Anchorless
 
, and DR1
 
b
 
G86Y
 
–HA
 
Anchorless
 
, and
dissociation sensograms were collected. DR1
 
b
 
G86Y
 
–HA
 
305–318
 
 sur-
face was used as a control surface for establishing the background
signal levels due to injection of DM.
For biosensor experiments with extended contact time, a BIA-
core X instrument was used in the external injection mode. Sam-
ples were delivered by an externally computer-controlled syringe
pump (model 402; Gilson) in a configuration similar to that de-
scribed previously (29), modified to allow the use of smaller sam-
ple volumes. Because of the temperature, 37
 
8
 
C, and long dura-
tion (3 h), microscopic bubbles formed that caused the unusual
appearance of the sensogram. For other experiments, we used a
BIAcore 2000.
 
Results
 
DR1
 
b
 
G86Y
 
 Molecules That Have a Shallow Pocket 1.
 
HA
 
Anchorless
 
 and HA
 
Y308A
 
 are short-lived peptides that disso-
ciate from DR1 with 
 
t
 
1/2
 
 of 30–120 min and thus leave
DR1 that is receptive to peptide binding. Experimental ev-
idence has shown that alanine substitution for threonine at
pocket 6 of HA
 
306–318
 
 sequence improved binding by three-
fold (30). To design a true HA
 
Anchorless
 
 peptide, we made a
threonine to glycine substitution at position 313 (20, 23).
To generate DR1 molecules that would not bind pep-
tides stably and would mimic kinetic and structural inter-
mediates, we designed a mutant DR1 molecule with a
shallow pocket 1 that would not allow fitting of a large an-
chor residue. A single site-specific mutation for glycine at
position 
 
b
 
86 to tyrosine was introduced. Residue 
 
b
 
86 was
chosen because DR alleles exhibit glycine-valine dimor-
phism at that position, suggesting that a bigger sidechain
would not cause gross structural changes in the protein. In
 
support of this, I-E
 
k 
 
has a phenylalanine for 
 
b
 
86 (31). 
 
b
 
G86
was changed to a tyrosine because HA
 
306–318
 
, which is both
the best binding and best characterized peptide of DR1, has
a tyrosine at that position as seen from the DR1–HA
 
306–318
 
crystal structure (32).
As predicted, DR1
 
b
 
G86Y
 
–HAAnchorless complexes dissoci-
ated with rates similar to that of wtDR1–HAAnchorless (Fig.
1) and exhibited a more rigid and compact structure resis-
tant to denaturation by SDS and heat, even in the absence
of peptides (23, 24; Table I). DR1bG86Y binds effectively to
peptides that contain alanine at the corresponding pocket 1
position via a kinetic on rate that fits a single exponential
equation (Fig. 2 a). This is in contrast to empty sDR1 that
binds the same peptide slowly via biphasic kinetics, and
maximal binding was not obtained even after 24 h of incu-
bation in the presence of 100 mM peptide (Fig. 2 b). The
binding of wtDR1 that has just lost tenant peptide, and is
in receptive form, follows a single exponential rate (Fig. 2
c). The biphasic kinetic relation in Fig. 2 b might be due to
heterogeneity of DR1 molecules, some binding peptide
rapidly and others that bind slowly. The fast phase might be
because of DR1 molecules in complex with unknown
short-lived peptides that dissociate rapidly.
Effect of DM on Peptide Release from Wt and DR1bG86Y.
Previous work has shown that DM enhances dissociation of
short-lived peptide–class II complexes (5, 8, 33–35). To
determine if DM affects the wt and DR1bG86Y in different
ways, we examined the molar ratio of DM necessary to fa-
cilitate dissociation of wtDR1 in complex with FITC-
HAAnchorless. At the lowest tested DM to wtDR1 ratio of
1:5, .40% of the complexes dissociated within 20 min in-
cubation (Fig. 3 a). However, after 40 min incubation,
.90% of complexes had dissociated (Fig. 3 b). In contrast,
DM did not affect dissociation of DRbG86Y–HAAnchorless at
this molar ratio. Furthermore, upon a 20-min incubation
(Fig. 3 a), only 10–15% of complexes dissociated at the
highest molar ratio. However, at the maximum ratio of
z1:1 of DM to DRbG86Y–HAAnchorless, only 50% of com-
plexes dissociated within 40 min (Fig. 3 b). For maximum
difference in dissociation of complexes of the wt and
DRbG86Y upon DM effects, we chose the DM/DR ratio of
1:2.5, and an incubation time of 20 min for future experi-
ments.
Figure 1. Peptide dissociation from wt and DR1bG86Y. Dissociation ki-
netics of wt (s) and sDR1bG86Y (d) complexes. DR1 in complex with
FITC-labeled HAAnchorless was produced and separated. The labeled com-
plexes were dissociated in the presence of 100 times molar excess of rele-
vant unlabeled peptides at 378C in PBS for various times. The fluores-
cence of the labeled complex before dissociation (f0) is arbitrarily assigned
a value of 1.0. The fluorescence of the labeled complex after dissociation
for various times is expressed as a percentage of f0. The dissociation data
are fitted to a single exponential curve that yields t1/2 of 1.8 6 0.25 h.
The y axis represents arbitrary fluorescence units.
Table I. DR1bG86Y Has a More Rigid Conformation
than WtDR1
MHC protein Pocket 1 SDS stability* Tm
‡
8C
DR1 (2P) Deep Unstable 67
DR1bG86Y (2P) Shallow Stable 72
DR1–HA306–318 2 Stable 84
*From references 23 and 24.
‡Tm, midpoint temperature of thermal denaturation of a protein (refer-
ence 24); 2P, without peptide.1700 DM Interacts with Floppy DR1
We compared the formation of FITC-peptide–MHC
complexes for the DR1bG86Y and wtDR1 in the presence
of 1 mM DM. Fig. 2, a and b, show comparison of associa-
tion rates of the DR1bG86Y and wtDR1 interacting with
HAAnchorless in the absence and after addition of DM. In the
absence of DM, a clear difference in the shape and the rates
of wt and DR1bG86Y binding to HAAnchorless established the
receptive conformation of the DR1bG86Y. Remarkably,
DM converted the biphasic peptide-binding pattern of
wtDR1 to the monophasic-binding pattern of DR1bG86Y.
A small (10–15%) increase in the plateau level might be due
to further stabilization of the DR1bG86Y by DM.
Peptide Binding of DR1 Assisted by DM in Real Time.
To determine the effects of DM on binding of receptive
DR1 to peptides and dissociation of complexes formed in
real time, we developed a peptide-binding assay by BIA-
Figure 2. The effects of DM on the generation of receptive DR1. (a
and b) The effects of DM on the binding of HAAnchorless peptide to wt and
DR1bG86Y. 2.4 mM DR1bG86Y (a) and wt (b) were incubated with 100
mM FITC-HAAnchorless peptide for various times in the absence (s) and
presence (j) of DM (1 mM, 0.15 M citrate phosphate buffer, pH 6.0, at
378C). The calculated rates for peptide binding to DR1bG86Y, in the ab-
sence and presence of DM, to wtDR1 in the presence of DM, and to the
receptive wtDR1, were all very similar and ranged between 0.47 and
0.61 s21mM21. (c) The kinetics of HA peptide binding to dissociating
DR1–HAAnchorless complex. 50 mM FITC-HA was incubated with 2.4
mM DR1–AMCA–HAAnchorless complex (isolated by size-exclusion chro-
matography, citrate buffer, pH 6.0) for various times at 378C. The un-
bound peptides were then removed by Sephadex G-50 spin columns in
PBS. Samples were read at two wavelengths of 345 (AMCA) and 514 nm
(fluorescein). The dissociation data (j) were fit to a single exponential
decay curve. The HA association (s) data were fit to a single exponential
binding curve.
Figure 3. The effects of DM on dissociation of DR1–peptide complex
in pH 6.0. 2.4 mM wtDR1 (black bars) and DR1bG86Y (white bars) in
complex with FITC–HAAnchorless were incubated with DM (citrate buffer,
pH 6.0) for 20 min (a) or 40 min (b), and dissociation of the complexes
was measured. At the physiological ratio of 1:5 DM/DR (reference 45),
DM did not affect dissociation of the DR1bG86Y–HAAnchorless complexes,
whereas at higher molar ratios, up to 50% of the complexes dissociated af-
ter 40 min of incubation.1701 Chou and Sadegh-Nasseri
hanced binding of wtDR1 to the peptide surface, perhaps
by increasing the dissociation of HAY308A from DR1 and by
maintaining the receptive conformation of the empty pro-
tein once the bound peptide was dissociated. The specific-
ity of DR1 binding to the peptide surface was tested by
mixing soluble HA306–318 peptide (5 mM) with wtDR1 1
min before injection over the peptide surfaces. As DR1 is
in receptive form, stable DR1–HA306–318 complexes form
in solution and therefore, when the sample is injected over
the peptide surface, no binding should occur (20). Indeed,
as shown, soluble HA306–318 blocked wtDR1 from binding
to HAAnchorless and HA305–318 surfaces.
In contrast to wtDR1 that bound to peptide sur-
face poorly in the absence of DM, DR1bG86Y bound to
HAAnchorless surface efficiently. Preincubation with DM in-
creased peptide binding by only 10–15%. Again, the result-
ant DR1bG86Y when in complex with soluble peptide failed
to bind to the immobilized peptide surface. Accessibility of
immobilized peptides for efficient binding might be a limi-
tation in this assay. Also, the competition between the dis-
sociated peptides (from DR1–HAY308A under the DM in-
fluence) present in the sample mixture together with DM
that enhances their binding as well may generate binding
profiles that represent slower rates than those that might be
obtained by solution studies. Nonetheless, the strength of
this assay is in measurement of fast dissociation rates such as
those shown in Fig. 5.
Figure 4. Peptide binding of DR1 by BIAcore SPR in real time. (a)
The  binding of DR1bG86Y to immobilized peptide in real time. Cys-
HAAnchorless peptide was immobilized in a biosensor flow cell and sen-
sograms were obtained by injection of DR1bG86Y–HAY308A complexes
(citrate buffer, pH 6.0). The long-term experiments were performed in a
BIAcore X instrument (for details, see Materials and Methods). The binding
curve is expressed as RU as a function of time. The DR1bG86Y–HAY308A
complexes were prepared by preincubation of DR1bG86Y and HAY308A
peptide followed by size-exclusion purification. Running buffer was ci-
trate buffer plus 0.01% Tween 20, pH 6.0. One out of two experiments is
shown. (b and c) The effects of DM on binding of the wtDR1 (b) and
DR1bG86Y (c) to the peptide surfaces; 2.4 mM wtDR1 or DR1bG86Y, in
complex with HAY308A peptide, was isolated by the procedure described
in the legend to Fig. 1, and then was incubated at 378C with or without 1
mM DM for 20 min. Samples (citrate buffer, pH 6.0) were injected over
three different peptide surfaces (cys-HA, cys-HAAnchorless, and the control
peptide) of BIAcore 2000 at a flow rate of 4 ml/min for 7 min followed by
washout (citrate buffer plus 0.01% Tween 20, pH 6.0) at a flow rate of 5
ml/min. Sensograms of DR1 binding are shown in different colors: in the absence of DM (blue), presence of DM (red), and DM plus soluble peptide
for blocking (green). One out of three experiments is shown.
core surface plasmon resonance (SPR), as the fluorescence
assay does not allow accurate measurement of very rapid
interactions. We took advantage of the fact that prior asso-
ciation with low affinity peptides induces a receptive con-
formation in class II (19, 20). First, DR1bG86Y was used to
establish the assay because it binds peptide more efficiently
and stays in receptive form once the peptide is dissociated
(20; Fig. 2 a). The peptide surfaces were generated first by
Cys coupling to the CM5 chip. Fig. 4 a shows a sensogram
of DR1bG86Y binding to the HAAnchorless surface. As the
steady-state binding can be reached 9,000 s after protein in-
jection, in the following experiments only the early bind-
ing curves were generated. The estimated dissociation rate
was 5.6 3 1025 s21, and the t1/2 z 3.4 h. This is in agree-
ment with the rates measured by the use of conventional
fluorescence assays (23; Fig. 1).
To examine formation of DR1–peptide complexes in
real time, HA305–318, HAAnchorless, and a non–DR1-binding
peptide, CLSPFPFDL,  were conjugated to different sur-
faces of a CM5 chip. Wt or DR1bG86Y was shaped to be re-
ceptive by incubating with short-lived HAY308A peptide
(see details in Materials and Methods) before it was injected
over the surface and binding was monitored. Fig. 4 b shows
wtDR1 binding to HAAnchorless and HA305–318 surfaces in the
presence and the absence of DM. Binding was significantly
higher if DM was preincubated with wtDR1 and was
present in the sample mix during the injection. DM en-1702 DM Interacts with Floppy DR1
Dissociation of the WtDR1 and DR1bG86Y from HAAnchorless
Surface by DM. The observation that DM did not act on
DR1bG86Y efficiently suggested that DM recognized con-
formations of empty pocket 1 of wtDR1. In the previous
experiment in Fig. 4, wtDR1 formed complexes with
HA306-318 and HAAnchorless peptide surfaces, and DR1bG86Y
formed complexes with HAAnchorless peptide on the bio-
sensor chip. Fig. 5 depicts the effects of injected DM on
the dissociation of these complexes. Only the wtDR1–
HAAnchorless surface showed a significant decrease (40 RU)
after DM injection (t1/2 z 3 min). The half-time for disso-
ciation of DR1bG86Y–HAAnchorless complexes in the presence
of DM was 135 min; thus, the presence of DM accelerated
dissociation of the wtDR1–HAAnchorless compared with the
DR1bG86Y–HAAnchorless complexes by 45-fold. The HA306–318
complexes dissociated within a t1/2 z 344 h that is consis-
tent with long-term solution studies, and was not acceler-
ated upon DM effects. The data clearly demonstrate that
DM effectively enhanced dissociation of wtDR1 in com-
plex with a peptide with alanine at pocket 1 position but
that the wtDR1–HA306–318 and DR1bG86Y–HAAnchorless sur-
faces were resistant to DM dissociation.
Measurements of Tryptophan Fluorescence upon DR1 and
DM Interaction. Wiley’s group (12) has suggested that two
tryptophan residues, a62 and b120, located on the lateral
surface of DM, are partially exposed and are candidates for
binding to DR. Moreover, a glycosylation mutant of DR
that interfered with DM effects was suggestive of the NH2-
terminal side of DR1 as a target for DM (36). We exam-
ined this possibility by detecting intrinsic tryptophan fluo-
rescence of wtDR1 and DR1bG86Y and DM. The intrinsic
tryptophan of each sample was excited at 295 nm to mini-
mize the interference of tyrosine fluorescence, and the
emission spectra were obtained from 310 to 500 nm. The
fluorescence spectra of DM and empty wtDR1 alone have
intensity maxima z340 nm (Fig. 6 a). These two spectra
can be additive if the DM and DR1 do not interact with
each other. However, if the DM and DR interact, causing
the exposed tryptophans to be buried at their interface,
tryptophan fluorescence should increase. In accord with
this, when DM and empty wtDR1 were mixed, the inten-
sity maxima of the emission fluorescence spectra increased
by 10–12% (Fig. 6 a). Consistent with the rapid rate of in-
teractions between DM and DR, there was no further sig-
nificant changes detected for wtDR1 and DM monitored
for 1 h after mixing (Fig. 6 a). Interestingly, mixing of DM
with wtDR1–HAAnchorless produced 7% increase in fluores-
cence (Fig. 6 b). Moreover, in agreement with the above
data that DR1bG86Y is not an optimal ligand for DM, empty
DR1bG86Y and DM did not yield increased fluorescence
(Fig. 6 c). In addition, no fluorescence increase was ob-
served when DM was mixed with the wtDR1–HA306–318
complex, suggesting lack of interactions that would bury
exposed tryptophans (Fig. 6 d). Overall, these observations
support the notion that DM interacts with empty and flex-
ible pocket 1 of DR1 and that the interaction causes burial
of exposed tryptophans present in DR1 and DM.
Discussion
In this paper, we show that DM may function through
conformational recognition. Several observations support
this model. Previously published results have proposed that
the stability of peptide–MHC complexes is the determinant
of DM reactivity. Our results here oppose this view by
providing evidence that the conformational differences in
an empty/flexible hydrophobic pocket 1 of DR1 is what is
recognized by DM.
Formation of peptide–MHC kinetic and structural inter-
mediate complexes leads to shaping of the peptide-binding
site of class II to a conformation that is highly receptive to
stable peptide binding. The rate-limiting step in the forma-
Figure 5. Dissociation of wt and
DR1bG86Y complexes by DM in real time.
Peptide–DR1 surfaces were generated as in
the legend to Fig. 4, and 9 mM DM was
passed through four different peptide–DR1
complex surfaces. For better comparison, all
surfaces indicating different RU values were
given zero values as the initiation point.
DR1bG86Y–HA surface was used as a nega-
tive control, as binding was negligible (Fig.
4). The negative sensograms are due to
lower salt concentration in DM-containing
buffer, and perhaps lack of Tween 20 that
was present in the running buffer. Shown
are wtDR1–HAAnchorless (red), wtDR1–HA
(blue), DR1bG86Y–HAAnchorless (red), and
the control mock DR1bG86Y–HA (blue).
In the presence of DM, dissociation rates for
the wtDR1–HAAnchorless were estimated to
be 3.8 3 1023 s21 ( t1/2  z  3.0 min); for
wtDR1–HA, 5.6 3 1027 s21 (t1/2 z 344 h);
and for the DR1bG86Y–HAAnchorless, 8.5 3
1025 s21 (t1/2 z 2.25 h). Inset, a replot of
data after subtraction of the mock DR1bG86Y–HA control surface to provide an easy evaluation of the dissociation rates of the complexes in the presence
of DM. One out of two experiments is shown.1703 Chou and Sadegh-Nasseri
tion of stable peptide binding is therefore the generation of
this peptide-receptive conformation. In this study, we have
used several experimental approaches and generated a mu-
tant DR1 with a single amino acid substitution inside its
pocket 1 to reduce the depth and hydrophobicity of this
pocket. The peptide-binding characteristics of DR1bG86Y
resemble that of wtDR1 in a peptide-receptive conforma-
tion (Fig. 2). The receptive characteristics of this mutant
might be due to the presence of tyrosine that partially fills
the pocket and prohibits the protein from stable peptide
binding. In addition, the presence of tyrosine induces rigid-
ity of pocket 1 as shown by resistance to SDS and an in-
crease in melting temperature (Tm) by 58C (Table I). This
rigidity may render empty DR1bG86Y less susceptible to col-
lapsing. We show that DM recognizes an intermediate
flexible conformation of wtDR1 that is characteristic of
empty DR1, or DR1 that is occupied with peptides lack-
ing the main anchor. This interaction generates and main-
tains a peptide-receptive form of the protein.
DR1bG86Y forms only short-lived complexes with pep-
tides yet serves as a poor substrate for DM function. As the
conformations of DR1bG86Y and wtDR1 in complex with
short-lived peptides are different, and DM can distinguish
these complexes, we propose that DM recognizes its sub-
strate via structural differences. In the absence of DM, a
clear difference in the shape and the rates of wt and
DR1bG86Y binding to HAAnchorless documents the receptive
conformation of the DR1bG86Y (Fig. 2).
It is remarkable that DM converts the biphasic peptide-
binding pattern of wtDR1 to the monophasic-binding pat-
tern of DR1bG86Y. A small (10–15%) increase in the plateau
level from the DM interaction might be the result of further
stabilization of the DR1bG86Y by DM. The earlier phase in
binding of wtDR1 in the presence of DM may represent
Figure 6. Interaction between
DM and DR1 involves intrinsic
tryptophan fluorescence changes. In-
trinsic tryptophan fluorescence of
DM interacting with empty wtDR1
(a), wtDR1–HAAnchorless (b), empty
DR1bG86Y (c), and wtDR1–HA (d)
complexes. DM and DR1 molecules
(in citrate buffer, pH 6.0) were
mixed and tryptophan fluorescence
was measured immediately (red) and
1 h after mixing (yellow) for wtDR1
plus DM sample. The intrinsic tryp-
tophans of each sample were excited
at 295 nm to minimize the interfer-
ence of tyrosine fluorescence and the
emission spectra were obtained from
310 to 500 nm. Measurements for
DM alone (green), DR alone (blue),
and the mathematical sum (dashed
line) are shown. The average fluo-
rescence intensities from two sepa-
rate measurements are plotted.1704 DM Interacts with Floppy DR1
binding of a cohort of the wtDR1 that is in receptive form
and binds peptide rapidly, whereas the second phase repre-
sents HLA-DR1 that binds peptide slowly (20). Similar bi-
phasic binding patterns have previously been observed for
DR1 molecules binding peptides in acidic, but not neutral
pH (19). Rabinowitz et al. also demonstrated that at acidic
pH, preshaped wtDR1 binding to HA306–318 peptide is
monophasic (19). Interestingly, adding DM to the empty
wtDR1 and peptide samples converts biphasic binding to
monophasic binding. The monophasic peptide-binding rate
is very similar to the binding rate of the DR1bG86Y and pre-
shaped wtDR1. This dramatic change in peptide-binding
pattern marks an important and novel function of DM: that
is, generation of a homogeneous population of MHC pro-
teins capable of binding peptides rapidly.
To further elucidate the mechanism catalyzed by DM,
we developed a real time peptide-binding assay. Although
the BIAcore SPR assay for binding of the MHC class I to
immobilized peptides has been successful (37, 38), this ap-
proach has failed for class II peptide binding, presumably
because the peptide-binding grooves of class II molecules
are either occupied, or collapse after peptide release (17).
As we and others now have established that class II mole-
cules can be shaped to a peptide-receptive conformation
that exhibits accelerated peptide association, it was likely
that direct MHC class II binding to peptides could be mea-
sured in real time. Using BIAcore SPR, we show that DM
assists peptide exchange more efficiently for wtDR1 than
for DR1bG86Y. A three- to fourfold increase in binding of
the DR1bG86Y (rate z119 3 1023 s21) versus wtDR1 (rate
z35 3 1023 s21) in binding to HAAnchorless surface in the
absence of DM was observed. A reason for a difference in
efficiency of DR1bG86Y in binding to the peptide surface
relative to the wt protein is the extreme susceptibility of
the wtDR1 in receptive form to partial denaturation unless
stabilized by loose binding to another peptide or DM. In
contrast, DR1bG86Y is mostly in receptive conformation
with little need for stabilization by either peptide or DM.
As preparations of wtDR1 had been incubated in the ab-
sence of DM for a minimum of 20 min before injection
over immobilized peptide surfaces, up to 50% of them (20)
have already converted to the low binding conformation
during this time. We also demonstrate, for the first time,
using SPR, that acceleration of peptide release with addi-
tion of DM only occurs with the wtDR1 in complex with
peptides that contain alanine instead of tyrosine at the cor-
responding pocket 1 position. Our SPR assay establishes
that analysis of the behavior of class II molecules can be
monitored in real time. Because of great sensitivity, inter-
actions of MHC II with peptides and other accessory mol-
ecules, such as DO with DM, can be studied in a more
controlled environment.
Can DM select its substrate by distinguishing the class II–
peptide complex stability? Our results show that the wt and
DR1bG86Y molecules that follow the same dissociation rates
for HAAnchorless or HAY308A are differentially recognized by
DM. This strongly suggests that DM recognizes a specific
and flexible conformation of class II rather than the previ-
ously proposed unstable MHC–peptide. The interaction
may resemble a chaperone function for DM. Just like a
chaperone that is required for proper folding and/or assem-
bly of another protein or protein complex, DM binds to a
partially folded flexible class II (18) that is either empty or
loosely bound to peptides. Because class II without a bound
peptide is prone to denaturation and peptide binding pre-
vents this process, DM facilitates binding and release of
loosely binding peptides until a peptide that can complete
the folding of the nascent protein is encountered (18).
Once a stable peptide–MHC complex is formed, the con-
formation of the complex is no longer suitable for DM
binding. At this point, class II is free to move to the cell
surface. This mechanism can also explain the suitability of
the DR1–CLIP complex as a DM substrate. Methionine,
which fits in pocket 1 of DR, has a distinctive flexible side
chain (39) that would not induce rigidity around pocket 1.
This pattern of recognition for DM is also consistent with
lack of recognition of I-Ek, which has a shallow pocket 1
(31) very similar to that of the DR1bG86Y (11, 40). More-
over, effects of H2-M on selection of immunodominant
epitopes of hen egg white lysozyme may reflect its prefer-
ence for more rigid ligand structures (41).
Intrinsic fluorescence assay showed that DM–DR inter-
action may involve the pocket 1 of DR1. An increase in
intrinsic fluorescence was observed when DM was mixed
with the wtDR1, whereas addition of DR1bG86Y or empty
wtDR1 in complex with HA306–318 peptide did not en-
hance fluorescence. The observed 10–12% change in tryp-
tophan fluorescence is significant because of minimal
changes in the control groups, i.e., complexes of wtDR1–
HA306–318 or DR1bG86Y–HAAnchorless, and the reproducibility
of these results. Thus, such a response pattern suggests that
the tryptophan-rich lateral surface of DM may be buried by
interactions with empty wtDR1. This is consistent with
predictions that Trp 62 on the lateral face of DM makes
contact with Phe 51 of DR around pocket 1 (12). Al-
though it has been shown that when DM and DR were
mixed, the nonpolar dye, anilinonaphthalene sulfonic acid
(ANS), which binds to hydrophobic patches of proteins,
emitted reduced fluorescence (42), the specific interaction
sites were not defined. Our findings substantiate that the
hydrophobic pocket 1 of DR1 is the main target for the
DM-induced conformational changes in this system.
The observations in this paper point to a central role for
conformational changes that take place upon peptide bind-
ing to MHC class II. These conformational adjustments
regulate class II peptide loading, trafficking to the proper
vesicular compartments, and cell surface expression. They
monitor interactions with DM and selection of peptides
that ultimately exit to the cell membrane and stimulate T
cells. It is likely that in class I presentation, a chaperone/ed-
itor protein, tapasin, also plays similar roles (43, 44). It will
be fascinating to find out if tapasin also functions through
mechanisms similar to those of DM.
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